Heron Therapeutics Inc banner

Heron Therapeutics Inc
NASDAQ:HRTX

Watchlist Manager
Heron Therapeutics Inc Logo
Heron Therapeutics Inc
NASDAQ:HRTX
Watchlist
Price: 0.9567 USD 2.09% Market Closed
Market Cap: $180.4m

Wall Street
Price Targets

HRTX Price Targets Summary
Heron Therapeutics Inc

Wall Street analysts forecast HRTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HRTX is 4.42 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

Lowest
Price Target
3.03 USD
217% Upside
Average
Price Target
4.42 USD
362% Upside
Highest
Price Target
6.3 USD
559% Upside
Heron Therapeutics Inc Competitors:
Price Targets
SMCP
SMCP SA
57% Upside
TENB
Tenable Holdings Inc
60% Upside
TELA
TELA Bio Inc
250% Upside
OFIX
Orthofix Medical Inc
37% Upside

Revenue
Forecast

49% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
49% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 14 years the compound annual growth rate for Heron Therapeutics Inc's revenue is 49%. The projected CAGR for the next 3 years is 19%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HRTX's stock price target?
Price Target
4.42 USD

According to Wall Street analysts, the average 1-year price target for HRTX is 4.42 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

What is Heron Therapeutics Inc's Revenue forecast?
Projected CAGR
19%

For the last 14 years the compound annual growth rate for Heron Therapeutics Inc's revenue is 49%. The projected CAGR for the next 3 years is 19%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett